SCHEMBL2003065

SCHEMBL2003065

[CH2]c1nncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1996650 0.63
SCHEMBL1101930 0.63
SCHEMBL14891491 0.62
SCHEMBL8156347 0.61 FBP1 (0.42)
SCHEMBL5457200 0.61 FBP1 (1.00)
SCHEMBL8878345 0.61 FBP1 (0.70)
SCHEMBL11119985 0.61
SCHEMBL10949129 0.59
SCHEMBL10089552 0.57
SCHEMBL3677847 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0247477-B1 1,2,3,6-TETRAHYDRO-5-NITRO-PYRIMIDINE DERIVATIVES BAYER AG (DE) 1990-06-27 EP claimed
US-4831036-A INSECTICIDES, NEMATICIDES, PARASITICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-05-16 US claimed
EP-0247477-A1 1,2,3,6-Tetrahydro-5-nitro-pyrimidine derivatives BAYER AG (DE) 1987-12-02 EP claimed
CN-110831926-B Tetrahydronaphtyl urea derivatives 持田制药株式会社 2023-11-21 CN disclosed
US-20220396643-A1 NOVEL CROSSLINKED ALGINIC ACID STRUCTURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2022-12-15 US disclosed
CN-111918881-B Novel photocrosslinkable alginic acid derivative 持田制药株式会社 2022-08-12 CN disclosed
EP-3131897-B1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME (US) 2022-06-15 EP disclosed
CN-114521199-A Novel cross-linked alginic acid structure 持田制药株式会社 2022-05-20 CN disclosed
US-20210380727-A1 NOVEL PHOTOCROSSLINKABLE ALGINIC ACID DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2021-12-09 US disclosed
US-20210147405-A1 BICYCLIC HETEROAROMATIC UREA OR CARBAMATE COMPOUNDS FOR USE IN THERAPY EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) 2021-05-20 US disclosed
WO-2021060336-A1 NOVEL CROSSLINKED ALGINIC ACID STRUCTURE 持田製薬株式会社 2021-04-01 WO disclosed
CN-1063104-A Trifluoromethyl 1-carbon (1-desulfuration) cephem LILLY CO ELI (US) 1992-07-29 CN disclosed
CN-1015103-B PROCESS FOR PREPARING 3-HALO-1-CARBO-3-CEPHEM-4-CARBOXYLIC ACID AND ITS DERIV. HARVARD COLLEGE (US) 1991-12-18 CN disclosed
EP-0247477-B1 1,2,3,6-TETRAHYDRO-5-NITRO-PYRIMIDINE DERIVATIVES BAYER AG (DE) 1990-06-27 EP disclosed
US-4831036-A INSECTICIDES, NEMATICIDES, PARASITICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-05-16 US disclosed
EP-0247477-A1 1,2,3,6-Tetrahydro-5-nitro-pyrimidine derivatives BAYER AG (DE) 1987-12-02 EP disclosed
CN-86105247-A Antibiotic intermediate and preparation method 1987-02-04 CN disclosed
EP-0034924-B1 PROCESS FOR PREPARING 3-IODOMETHYL CEPHALOSPORINS ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed
EP-0034924-A2 Process for preparing 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-09-02 EP disclosed
US-4266049-A Process for 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-05-05 US disclosed